Compare TDY & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDY | TEVA |
|---|---|---|
| Founded | 1960 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8B | 30.2B |
| IPO Year | 2000 | N/A |
| Metric | TDY | TEVA |
|---|---|---|
| Price | $668.72 | $34.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $627.88 | $37.25 |
| AVG Volume (30 Days) | 374.0K | ★ 9.5M |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 13.06 | N/A |
| Revenue | ★ $1,020,400,000.00 | N/A |
| Revenue This Year | $5.52 | N/A |
| Revenue Next Year | $5.08 | $2.97 |
| P/E Ratio | $51.16 | ★ $28.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $419.00 | $12.47 |
| 52 Week High | $674.63 | $37.35 |
| Indicator | TDY | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 67.68 | 50.68 |
| Support Level | $645.30 | $33.70 |
| Resistance Level | $674.63 | $35.32 |
| Average True Range (ATR) | 17.83 | 1.04 |
| MACD | -1.09 | -0.22 |
| Stochastic Oscillator | 85.74 | 4.45 |
Teledyne Technologies Inc sells technologies for industrial markets. Roughly a fourth of Teledyne's revenue comes from contracts with the United States government. The firm operates in four segments: instrumentation, digital imaging, aerospace and defense electronics, and engineered systems. The instrumentation segment provides monitoring instruments primarily for marine and environmental applications. The digital imaging segment contributes majority of proportion of revenue and includes image sensors and cameras for industrial, government, and medical customers. The aerospace and defense electronics segment provides electronic components and communication products for aircraft. The engineered systems segment provides solutions for defense, space, environmental, and energy applications.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.